by Dr. Alan Oxley, Chairman APEC Centre, RMIT University, Melbourne IFPMA Geneva Pharma Forum on 24 November 2009
Read moreby Mr. Thaddeus Burns Senior Counsel, IP & Trade, General Electric
Read moreby Mr. Thaddeus Burns Senior Counsel, IP & Trade, General Electric
Read moreby Dr. Markus Boehringer, Vicedirector, Section Head Metabolic Diseases, Hoffmann — La Roche, Basel IFPMA Geneva Pharma Forum on 24 November 2009
Read moreby Dr. Markus Boehringer, Vicedirector, Section Head Metabolic Diseases, Hoffmann — La Roche, Basel IFPMA Geneva Pharma Forum on 24 November 2009
Read moreby Prof. Wim Vanhaverbeke Hasselt University (Belgium), ESADE Business School (Spain) [Side Event at WIPO General Assemblies on 22nd September 2010]
Read moreby Prof. Wim Vanhaverbeke Hasselt University (Belgium), ESADE Business School (Spain) [Side Event at WIPO General Assemblies on 22nd September 2010]
Read moreDr. Konji Sebati Senior Advisor, Global Issues, WIPO [Side Event at WIPO General Assemblies, on 22nd September 2010]
Read moreby Mr. Stéphane Tronchon Director IP Europe, Qualcomm [Side Event at WIPO General Assemblies on 22nd September 2010]
Read moreby Mr. Robert DeBerardine Global Head of Patents, sanofi-aventis [Side Event at WIPO General Assemblies on 22nd September 2010]
Read moreby Axel Braun Geneva Pharma Forum: on 24 November 2009
Read moreThe International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) is pleased to announce that Biogen Idec Inc. has joined the Federation, thus bringing its membership up to 29 leading international companies and 44 national and regional industry associations. IFPMA Director General Eduardo Pisani said: “We are delighted to welcome Biogen Idec, a pioneering biotech company,...
Read more